Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers
- Sarah T. Diepstraten
- , Yin Yuan
- , John E. La Marca
- , Savannah Young
- , Catherine Chang
- , Lauren Whelan
- , Aisling M. Ross
- , Karla C. Fischer
- , Giovanna Pomilio
- , Rhiannon Morris
- , Angela Georgiou
- , Veronique Litalien
- , Fiona C. Brown
- , Andrew W. Roberts
- , Andreas Strasser
- , Andrew H. Wei
- , Gemma L. Kelly
- Walter and Eliza Hall Institute of Medical Research
- University of Melbourne
- Peter Maccallum Cancer Centre
- Olivia Newton-John Cancer Research Institute
- Monash University
Research output: Contribution to journal › Article › peer-review